[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastric-adenocarcinoma:msi1-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastric Adenocarcinoma","MSI1 Gene",5,[8,16,22,29,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06203600","Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial",[12],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:17:28.381459Z","2026-05-05T02:43:28.966545Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07001748","Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity",[12],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.952061Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06824363","ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w\u002FARID1a Mu",[26],"Early Phase 1","2026-08-26T02:15:17.167444Z","2026-05-05T02:43:26.849550Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT04114136","Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies",[33],"Phase 2","2026-08-26T02:18:18.766496Z","2026-05-05T02:43:26.717214Z",{"nct_id":37,"title":38,"phases":39,"status":41,"updated_at":42,"content_modified":43},"NCT07594548","Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma",[40],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:17:36.611194Z","2026-05-29T15:36:40.205969Z"]